| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |